Advertisement

ACR: Incidence of COVID-19 Low in Patients With Rheumatic Disease

0

73 percent of those with SARS-CoV-2 infection not hospitalized; 11 percent of those hospitalized required ICU admission

Mental Health ED Visits in Children Up Mid-March to October 2020

0

Proportion of mental health-related ED visits increased 24 and 31 percent for children, adolescents

Major Neurological Disorders on the Rise in the United States

CDC: 26.4 Percent of U.S. Adults With Diabetes Meet ABCS Goals

0

About one in four meet combined goals of management of blood glucose, BP, non-HDL-C, avoiding smoking

Physician's Briefing Weekly Coronavirus Roundup

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
COVID-19 Patients More Often Have Vitamin D Deficiency

9 Percent Readmitted After Index COVID-19 Hospitalization

0

Odds of hospital readmission increased with age, presence of chronic conditions, hospitalization within previous three months

COVID-19-Linked Ischemic Strokes More Severe

NHLBI Trial Concludes No Benefit for Hydroxychloroquine in COVID-19

0

No clinical benefit found for hydroxychloroquine versus placebo in hospitalized adults with COVID-19

Nearly 74 Million Essential Workers at High Risk for COVID in U.S.

AHA: Patient CPR Outcomes Similar With COVID-19 Precautions

0

No negative impact on survival found with additional safety precautions for health care personnel during COVID-19

COVID-19 at Forefront of IDWeek Discussions

0

IDWeek chairs Inger Damon, M.D., and Tom Talbot, M.D., discuss this year's annual meeting with HD Live!

E. Coli Outbreak May Be Linked to Recalled Romaine Lettuce

0

Five patients have been hospitalized; no deaths have been reported

HealthDay Reports: Nearly Half of Coronavirus Infections May Be Asymptomatic

Antibody Treatment Approved for Emergency Use Against Early COVID-19

0

Treatment approved for people newly infected with COVID-19 who are at high risk for progressing to severe disease